U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774325) titled 'A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood' on Aug. 17.

Brief Summary: The main objective of this trial is to investigate the effects of multiple doses of Itraconazole and multiple doses of Ciclosporin on the pharmacokinetics of BI 3000202 in plasma following a single oral dose in healthy male trial participants.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: BI 3000202

BI 3000202

DRUG: Ciclosporin

Ciclosporin

DRUG: Itraconazole

Itraconazole

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Boehringe...